-
Optimal adjuvant therapy for resected pancreatic cancer: chemotherapy or chemoradiotherapy?
Garofalo MC, Nichols EM, Regine WF.
Gastrointest Cancer Res. 2007 Sep; 1(5):182-7.
[Gastrointest Cancer Res. 2007]
-
Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO).
Brunner TB, Grabenbauer GG, Meyer T, Golcher H, Sauer R, Hohenberger W.
BMC Cancer. 2007 Mar 6; 7:41. Epub 2007 Mar 6.
[BMC Cancer. 2007]
-
On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer.
Garofalo MC, Regine WF, Tan MT.
Ann Surg. 2006 Aug; 244(2):332-3; author reply 333.
[Ann Surg. 2006]